PRLD
Prelude Therapeutics Inc
Price:
0.82
USD
Volume:
79,559
United States | Biotechnology
PRLD Current Ratio
As of 2025-07-15, the Current Ratio of Prelude Therapeutics Inc (PRLD) is 5.3.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
PRLD Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 5.3 |
| 2023-12-31 | 10.79 |
| 2022-12-31 | 9.42 |
| 2021-12-31 | 15.37 |
| 2020-12-31 | 19.37 |
| 2019-12-31 | 4.21 |
| 2018-12-31 | 6.5 |
| - | |
| - | |
| - |
PRLD Current Ratio - Peers Comparison